vimarsana.com

Latest Breaking News On - Matthews abbott - Page 6 : vimarsana.com

Chemours (NYSE:CC) Price Target Raised to $40.00 at Barclays

Chemours (NYSE:CC – Free Report) had its target price upped by Barclays from $38.00 to $40.00 in a research report released on Tuesday, FlyOnTheWall reports. Several other analysts also recently weighed in on CC. BMO Capital Markets lifted their price objective on shares of Chemours from $54.00 to $64.00 in a research report on Monday, […]

Canada
United-states
America
Asia-pacific
Matthews-abbott
Mark-newman
Commonwealth-equity-services
Specialized-solutions
Securities-exchange-commission
Baird-financial-group-inc
Chemours-company
Royal-bank

Chemours (NYSE:CC) Price Target Increased to $40.00 by Analysts at Barclays

Chemours (NYSE:CC) Price Target Increased to $40.00 by Analysts at Barclays
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
America
Matthews-abbott
Mark-newman
Asia-pacific
Securities-exchange-commission
Barclays
Brown-advisory-inc
Specialized-solutions
Commonwealth-equity-services
Baird-financial-group-inc

The Chemours Company (NYSE:CC) Receives $38.44 Average Price Target from Brokerages

The Chemours Company (NYSE:CC – Free Report) has received an average recommendation of “Hold” from the ten brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating on the company. The average 1-year […]

United-states
Canada
Montreal
Quebec
America
Mark-newman
Asia-pacific
Matthews-abbott
Credit-suisse-group
Securities-exchange-commission
Chemours-company
Cetera-advisor-networks

The Chemours Company (NYSE:CC) Shares Sold by Bourgeon Capital Management LLC

Bourgeon Capital Management LLC decreased its position in shares of The Chemours Company (NYSE:CC – Get Rating) by 71.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,000 shares of the specialty chemicals company’s stock after selling 25,650 shares during the quarter. […]

Blackrock
Nova-scotia
Canada
United-states
America
Mark-newman
Matthews-abbott
Norges-bank
Vanguard-group-inc
Balyasny-asset-management
Credit-suisse-group
Chemours-co

Chemours (NYSE:CC) Stock Rating Lowered by Bank of America

Chemours (NYSE:CC – Get Rating) was downgraded by equities researchers at Bank of America from a “buy” rating to a “neutral” rating in a report issued on Thursday, The Fly reports. They presently have a $37.00 price target on the specialty chemicals company’s stock, down from their previous price target of $41.00. Bank of America‘s […]

Canada
United-states
America
Mark-newman
Matthews-abbott
Royal-bank
Wealth-strategies-group
Credit-suisse-group
Chemours-co
Tanglewood-legacy-advisors
Lindbrook-capital
Securities-exchange-commission

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.